Omeprazol Gp (Omeprazole)

Omeprazole irreversibly inhibits the H+/K+‑ATPase enzyme, also known as the gastric proton pump, on the secretory surface of parietal cells. By blocking this final step of acid secretion, it markedly lowers both basal and stimulated gastric acidity, providing symptom relief and allowing ulcer healing.

The appropriate dose of Omeprazol Gp is determined by the prescribing healthcare professional based on the specific indication, patient age, renal and hepatic function, and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Omeprazole is classified as pregnancy category C in many regions, meaning risk cannot be ruled out. It should only be used during pregnancy or lactation if the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers should evaluate each case individually.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The team then replies with pricing, availability, shipping details and any required import documentation.

Omeprazol Gp belongs to the proton pump inhibitor (PPI) class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with newer PPIs, omeprazole has a well‑established efficacy and safety profile, though individual response and drug‑interaction potential may vary.

Omeprazol Gp tablets should be stored at room temperature, below 25 °C, in the original container to protect them from moisture and light. Do not store in a bathroom or near a heat source, and keep out of reach of children.

Omeprazol Gp is taken orally, usually as a whole tablet with a glass of water. For optimal absorption, it is recommended to swallow the tablet before a meal, typically in the morning, unless the prescriber advises a different schedule.

Serious risks, though uncommon, include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, low magnesium levels (hypomagnesemia), and increased risk of bone fractures with long‑term use. Patients should seek immediate medical attention if they experience rash, persistent diarrhea, muscle cramps, or unexplained bone pain.

Individuals with known hypersensitivity to omeprazole, other proton pump inhibitors, or any component of the formulation should avoid Omeprazol Gp. Caution is also advised for patients with severe liver disease, those taking interacting medications such as clopidogrel, and patients who are pregnant or breastfeeding without medical supervision.